Targeting CD39 in cancer reveals an extracellular ATP-and inflammasome-driven tumor immunity

Author(s):

Xian Yang Li, Achim K. Moesta, Christos Xiao, Kyohei Nakamura, Mika Casey, Haiyan Zhang, Jason Madore, Ailin Lepletier, Amelia Roman Aguilera, Ashmitha Sundarrajan, Celia Jacoberger-Foissac, Clifford Wong, Tracy de la Cruz, Megan Welch, Alana G. Lerner, Bradley N. Spatola, Vanessa B. Soros, John Corbin, Ana C. Anderson, Maike Effern, Michael Hölzel, Simon C. Robson, Rebecca L. Johnston, Nicola Waddell, Corey Smith, Tobias Bald, Nishamol Geetha, Courtney Beers, Michele W.L. Teng, Mark J. Smyth

Details:

Cancer Discovery, Volume 9, Issue 12, 2019-12-01

Article Link: Click here

Affiliations:

• Brigham and Women's Hospital
• Beth Israel Deaconess Medical Center
• Universitätsklinikum Bonn
• QIMR Berghofer Medical Research Institute
• Department of Microbiology & Immunology
• Tizona Therapeutics